Search Results - "Ong, Eugenia Z"
-
1
Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness
Published in Science (American Association for the Advancement of Science) (09-10-2015)“…The global spread of dengue virus (DENV) infections has increased viral genetic diversity, some of which appears associated with greater epidemic potential…”
Get full text
Journal Article -
2
Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes
Published in PLoS biology (31-05-2022)“…Ensuring high vaccination and even booster vaccination coverage is critical in preventing severe Coronavirus Disease 2019 (COVID-19). Among the various…”
Get full text
Journal Article -
3
Viral Manipulation of Host Inhibitory Receptor Signaling for Immune Evasion
Published in PLoS pathogens (01-09-2016)“…Eugenia Z. Ong Affiliation: Experimental Therapeutics Centre, Agency for Science, Technology, and Research, Singapore Kuan Rong Chan Affiliation: Programme in…”
Get full text
Journal Article -
4
Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue
Published in Proceedings of the National Academy of Sciences - PNAS (18-02-2014)“…Viruses must evade the host innate defenses for replication and dengue is no exception. During secondary infection with a heterologous dengue virus (DENV)…”
Get full text
Journal Article -
5
An experimental medicine decipher of a minimum correlate of cellular immunity: Study protocol for a double-blind randomized controlled trial
Published in Frontiers in immunology (10-03-2023)“…Vaccination induces an adaptive immune response that protects against infectious diseases. A defined magnitude of adaptive immune response that correlates with…”
Get full text
Journal Article -
6
Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein
Published in PLoS neglected tropical diseases (09-02-2018)“…Dengue virus (DENV) infection imposes enormous health and economic burden worldwide with no approved treatment. Several small molecules, including lovastatin,…”
Get full text
Journal Article -
7
A fast-growing dengue virus mutant reveals a dual role of STING in response to infection
Published in Open biology (01-12-2022)“…The four dengue viruses (DENVs) have evolved multiple mechanisms to ensure its survival. Among these mechanisms is the ability to regulate its replication…”
Get full text
Journal Article -
8
A systematic approach to the development of a safe live attenuated Zika vaccine
Published in Nature communications (12-03-2018)“…Zika virus (ZIKV) is a flavivirus that can cause congenital disease and requires development of an effective long-term preventative strategy. A replicative…”
Get full text
Journal Article -
9
Electron transport chain capacity expands yellow fever vaccine immunogenicity
Published in EMBO molecular medicine (14-06-2024)“…Vaccination has successfully controlled several infectious diseases although better vaccines remain desirable. Host response to vaccination studies have…”
Get full text
Journal Article -
10
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine
Published in npj vaccines (13-12-2022)“…Coronavirus disease-19 (Covid-19) pandemic have demonstrated the importantance of vaccines in disease prevention. Self-amplifying mRNA vaccines could be…”
Get full text
Journal Article -
11
Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution
Published in EBioMedicine (01-03-2021)“…The coronavirus disease-19 (COVID-19) pandemic has cost lives and economic hardships globally. Various studies have found a number of different factors, such…”
Get full text
Journal Article -
12
Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection
Published in EBioMedicine (01-11-2020)“…The emergence of Zika virus (ZIKV) as an important cause of congenital and childhood developmental disorders presents another challenge to global health…”
Get full text
Journal Article -
13
Therapeutic antibodies as a treatment option for dengue fever
Published in Expert review of anti-infective therapy (01-11-2013)“…Dengue fever is the most prevalent mosquito-borne viral disease globally with about 100 million cases of acute dengue annually. Severe dengue infection can…”
Get more information
Journal Article -
14
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine
Published in npj vaccines (28-11-2022)“…Remarkable potency has been demonstrated for mRNA vaccines in reducing the global burden of the ongoing COVID-19 pandemic. An alternative form of the mRNA…”
Get full text
Journal Article -
15
Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset
Published in Med (New York, N.Y. : Online) (11-06-2021)“…RNA vaccines against coronavirus disease 2019 (COVID-19) have demonstrated ∼95% efficacy in phase III clinical trials. Although complete vaccination consisted…”
Get more information
Journal Article -
16
Publisher Correction: Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children
Published in Nature medicine (01-07-2024)Get full text
Journal Article -
17
Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children
Published in Nature medicine (01-05-2024)“…The paucity of information on longevity of vaccine-induced immune responses and uncertainty of the correlates of protection hinder the development of…”
Get full text
Journal Article -
18
Dengue virus compartmentalization during antibody-enhanced infection
Published in Scientific reports (13-01-2017)“…Secondary infection with a heterologous dengue virus (DENV) serotype increases the risk of severe dengue, through a process termed antibody-dependent…”
Get full text
Journal Article -
19
Phase 1 Trial of a Therapeutic Anti–Yellow Fever Virus Human Antibody
Published in The New England journal of medicine (30-07-2020)“…A phase 1a–1b trial of TY014, an IgG1 anti–yellow fever virus monoclonal antibody, did not identify worrisome safety signals. Ten participants were randomly…”
Get full text
Journal Article -
20
Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope
Published in Cell host & microbe (09-05-2018)“…Following the recent emergence of Zika virus (ZIKV), many murine and human neutralizing anti-ZIKV antibodies have been reported. Given the risk of virus escape…”
Get full text
Journal Article